Jubilant Ingrevia Ltd
As of 16 Oct 2026, Jubilant Ingrevia is in Stage 3 — topping, where an uptrend loses steam, in week 3 (since 25 Sep 2026). It closed at ₹631, 17.4% below its 52-week high and below its 200-day average, which is falling. In Materials, 34.1% of stocks are in Stage 2.
Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is JUBLINGREA early, or has it already run? Pro answers that for every NSE stock, after every close.
About this companyMaterials· Specialty Chemicals
Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol. In addition, it provides vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. The company serves pharmaceutical, nutrition, agrochemical, consumer, and industrial sectors. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is headquartered in Noida, India.
Visit company website →All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.